CovidVax show full list

Molecular clamp stabilized Spike protein

University of Queensland + GSK + Dynavax + Viroclinics Xplore + CSL Limited
vaccine type: Protein subunit
Distribution updates
Sep 06CSL Ltd has signed today a HoA with the Australian Gov to supply 51 million doses of QueensUni's vaccine (by
Human Testing updates (clinical trials)



started July 14 2020

with 120 healthy volunteers aged 18-55

trial location: Australia

» clinical trial details

Jul 13Queensland Uni started dosing healthy adult participants in a Phase 1 clinical trial of its vaccine (by
Jul 13The Phase 1 trial of QueensUni's vaccine will involve 120 volunteers with results in 3 months (by
Apr 09University of Queensland expects to start clinical trials for its vaccine in Q3 2020 (by
Animal Testing updates (pre-clinical trials)
start date: April 2020
Apr 09The vaccine developed by the Queensland Uni has progressed into preclinical studies (by
early development updates
Mar 21QueensUni expects to cut the time by six months in which a vaccine may be available (by

Coalition for Epidemic Preparedness (CEPI) + Queensland Government + Australian Government
Mar 22University of Queensland received AU$17M funding from Australian institutions (by
Jun 05QueensUni and CEPI have started a partnership to speed up development and manufacturing (by
Apr 09Dutch firm Viroclinics Xplore partners with Queensland Uni on the preclinical studies (by
Mar 02Dynavax announced collaboration with QueensUni to provide adjuvant for the vaccine (by
Feb 03Queensland Uni will be able to test GSK adjuvant in its vaccine thanks to CEPI support (by

contact | about | ©2020 project